The duration of each participant's participation was approximately 28 days (Day 0 through Day 28 [+ 7 days]).
Primary Objective:~Immunogenicity: To describe the immune response induced by high-dose quadrivalent influenza vaccine (QIV-HD) and AdimFlu-S (QIS) by hemagglutinin inhibition (HAI) measurement method in all participants.~Safety: To describe the safety profile of all participants in each study groups.